Weekly highlights
Hey {{first_name}}! Here’s what’s happening this week
Something worth your attention came through this week as always.
Reliance has been on my radar the last few days — and after going through everything in depth, there's a setup here that's genuinely interesting, but not in the way most of the coverage I've seen is framing it.
The Jio IPO headline is doing most of the work in analyst notes right now. And yes, it matters. But there's a margin story sitting underneath it that I think is being glossed over — and if you're building or adjusting a position, that's the thing you really need to have a clear view on first.
A few other names came up this week too. HDFC Bank has a setup that's been quietly developing, and there's something worth watching in commodities. More on those below.
Equity
RIL: Jio IPO catalyst vs margin compression risk
On 21 June, 5:43pm
Comprehensive analysis complete Jun'26. SOTP fair value ₹1,500-1,800.
Key risk: Q4 FY26 PAT margin collapse 12.4%→6.9% (550bps).
Key catalyst: Jio IPO DRHP filed Jun 19. CMP ₹1,310 offers favorable entry for patient capital.
Binary event: Q1 FY27 results Jul'26.
Equity
RIL: Jio IPO catalyst vs margin compression risk
On 21 June, 5:43pm
Comprehensive analysis complete Jun'26. SOTP fair value ₹1,500-1,800.
Key risk: Q4 FY26 PAT margin collapse 12.4%→6.9% (550bps).
Key catalyst: Jio IPO DRHP filed Jun 19. CMP ₹1,310 offers favorable entry for patient capital.
Binary event: Q1 FY27 results Jul'26.
Equity
RIL: Jio IPO catalyst vs margin compression risk
On 21 June, 5:43pm
Comprehensive analysis complete Jun'26. SOTP fair value ₹1,500-1,800.
Key risk: Q4 FY26 PAT margin collapse 12.4%→6.9% (550bps).
Key catalyst: Jio IPO DRHP filed Jun 19. CMP ₹1,310 offers favorable entry for patient capital.
Binary event: Q1 FY27 results Jul'26.
About Kubera
How is this put together
Quick note on where all of this comes from — because I get asked.
None of this is a team of analysts working through the weekend. It's Kubera — an agentic intelligence system I've built that runs continuously across the markets we track. A researcher agent monitors news, filings, corporate events, and macro signals as they happen. An analyst agent processes all of it, looks for patterns, gaps, and inflection points, and surfaces the things that actually matter. I review what it flags, add context where needed, and send it to you.
Every insight in this newsletter is the output of that pipeline — not a one-time build, not a static model. It runs 24/7, updates as new data comes in, and gets sharper over time.
The reason I'm sharing this publicly is simple: the best way to show what Kubera can do is to just show what Kubera does.
If you manage a fund, a portfolio, or a trading book — this is deployable for your specific universe. Your watchlist, your strategy, your investment style. The agents get built around how you actually think and operate, not a generic template.
If you want to see what this looks like configured for your firm — 30 minutes, no slides, just a live walkthrough.
That’s it for this week.
More coming as Kubera keeps running and surfacing valuable insights across global markets
As always, if something in here prompts a question or a different take — just reply. I read everything.
Read more about Kubera here.
— Santhosh
Founder, Om Labs · Kubera
The insights in this newsletter are produced by Kubera, an AI-powered market intelligence system developed by Om Labs. All content is for informational purposes only and does not constitute financial, investment, or trading advice. Nothing here should be interpreted as a recommendation to buy, sell, or hold any security or financial instrument. Markets involve risk.